Altamira Therapeutics Ltd
CYTO
CYTO was delisted on the 19th of December, 2024.
4 hedge funds and large institutions have $113K invested in Altamira Therapeutics Ltd in 2020 Q2 according to their latest regulatory filings, with 2 funds opening new positions, increasing their positions, 2 reducing their positions, and 2 closing their positions.
19% more capital invested
Capital invested by funds: $95K → $113K (+$18K)
0% more funds holding
Funds holding: 4 → 4 (0)
0% more first-time investments, than exits
New positions opened: 2 | Existing positions closed: 2
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
+$53.7K |
| 2 |
WS
Wedbush Securities
Los Angeles,
California
|
+$49.2K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SM
Sabby Management
Miami Beach,
Florida
|
-$72K |
| 2 |
UBS Group
Zurich,
Switzerland
|
-$6.01K |
| 3 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$5K |
| 4 |
Morgan Stanley
New York
|
-$4.88K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Renaissance Technologies
New York
| $54K | +$53.7K | +143 | New |
|
|
WS
2
Wedbush Securities
Los Angeles,
California
| $49K | +$49.2K | +131 | New |
|
|
3
Morgan Stanley
New York
| $9K | -$4.88K | -13 | -35% |
|
|
4
UBS Group
Zurich,
Switzerland
| $1K | -$6.01K | -16 | -84% |
|
|
SM
5
Sabby Management
Miami Beach,
Florida
| – | -$72K | -224 | Closed |
|
|
6
Deutsche Bank
Frankfurt Am Main Ge,
Germany
| – | -$5K | -16 | Closed |
|
CYTO Hedge Fund Activity: Q2 2020 in Review
4 of the 4,877 institutional investors tracked by Wall St. Rank reported a position in Altamira Therapeutics Ltd (CYTO) for Q2 2020, worth a combined $113K — up 19% from $95K a quarter earlier.
Fund positioning in CYTO was balanced in Q2 2020: 2 funds opened new positions, 2 closed out, 0 added to existing stakes and 2 trimmed.
The largest buyer was Renaissance Technologies, opening a new position worth an estimated $53.7K. The largest seller was Sabby Management, exiting entirely with an estimated $72K sold.
- 4 institutional investors held Altamira Therapeutics Ltd (CYTO) as of Q2 2020, unchanged from Q1 2020.
- Funds reported $113K of Altamira Therapeutics Ltd stock for Q2 2020, up 19% quarter-over-quarter.
- 2 funds opened new Altamira Therapeutics Ltd positions in Q2 2020 and 2 closed out, a net change of 0 holders.
- The largest Altamira Therapeutics Ltd buyer in Q2 2020 was Renaissance Technologies, an estimated $53.7K added.
- The largest Altamira Therapeutics Ltd seller in Q2 2020 was Sabby Management, an estimated $72K sold.
Based on aggregated 13F filings for Q2 2020.